Search research articles
Contact Us
Filters
Showing results (1-10 of 336) with videos related to
Page
of 34
Sort By:
Anticancer Research
|
July 3, 2019
From 'Targeted Therapy' to Targeted Therapy
Godefridus J Peters
Therapeutic Advances in Medical Oncology
|
November 12, 2015
Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
May 4, 2018
Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
January 22, 2019
Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
August 1, 2024
Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
June 19, 2014
Novel developments in the use of antimetabolites
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
December 2, 2016
Advances in purine and pyrimidine metabolism in health and diseases
Michio Hirano, Godefridus J Peters
Pharmacogenomics
|
October 13, 2012
Highlights from the latest articles in pharmacogenomics of irinotecan/cisplatin toxicity
Godefridus J Peters, Elisa Giovannetti
Cancer Chemotherapy and Pharmacology
|
December 26, 2015
Contemporary reviews on cancer treatment
Godefridus J Peters, Eric Raymond
Amino Acids
|
October 19, 2016
Glutamate and α-ketoglutarate: key players in glioma metabolism
Andreas Maus, Godefridus J Peters
Page
of 34
Search research articles
Search
Showing results (1-10 of 336) with videos related to
Sort By:
Page
of 34
Anticancer Research
|
July 3, 2019
From 'Targeted Therapy' to Targeted Therapy
Godefridus J Peters
Therapeutic Advances in Medical Oncology
|
November 12, 2015
Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
May 4, 2018
Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
January 22, 2019
Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
August 1, 2024
Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
June 19, 2014
Novel developments in the use of antimetabolites
Godefridus J Peters
Nucleosides, Nucleotides & Nucleic Acids
|
December 2, 2016
Advances in purine and pyrimidine metabolism in health and diseases
Michio Hirano, Godefridus J Peters
Pharmacogenomics
|
October 13, 2012
Highlights from the latest articles in pharmacogenomics of irinotecan/cisplatin toxicity
Godefridus J Peters, Elisa Giovannetti
Cancer Chemotherapy and Pharmacology
|
December 26, 2015
Contemporary reviews on cancer treatment
Godefridus J Peters, Eric Raymond
Amino Acids
|
October 19, 2016
Glutamate and α-ketoglutarate: key players in glioma metabolism
Andreas Maus, Godefridus J Peters
Page
of 34